Hemovent Overview

  • Founded

  • 2013

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 20

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $143M

Hemovent General Information

Description

Developer of a medical device designed to support or replace heart and lung functions in the event of cardiac or respiratory failure. The company's device provides respiratory support to patients whose lungs are so damaged that they cannot perform their basic functions and acts as a temporary life support system by taking over the hearts function in case of an acute heart failure, thus providing hospitals with enough time to address the underlying problems that caused the failure.

Contact Information

Website
www.hemovent.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Parent Company
MicroPort Surgical
Primary Office
  • Pascalstraße 59
  • 52076 Aachen
  • Germany
+49 0241 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemovent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 13-Oct-2021 $143M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series B) 07-Jul-2020 000.00 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2019 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 25-Jul-2017 00.00 000.00 000.00 Completed Generating Revenue
2. Grant 24-Apr-2017 $810K $6M Completed Generating Revenue
1. Early Stage VC (Series A) 10-Feb-2016 $6M $6M 000.00 Completed Generating Revenue
To view Hemovent’s complete valuation and funding history, request access »

Hemovent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to support or replace heart and lung functions in the event of cardiac or respira
Therapeutic Devices
Aachen, Germany
20 As of 2021
000.00
0000 0000-00-00
000000&0 000.00

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
00000000000 0000000
Danvers, MA
0000 As of 0000
000.00
000 0000-00-00
000000&0 000.00

000000

ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
00000000000 0000000
London, United Kingdom
0000 As of 0000
000.00
0.00 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hemovent Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abiomed Corporation Danvers, MA 0000 000.00 000000&0 000.00
00000000 Formerly VC-backed London, United Kingdom 0000 000.00 000000000000
000000 Formerly VC-backed Heilbronn, Germany 000 000000&0
00000000 Corporation Medolla, Italy 000
000000 Corporation Tokyo, Japan 00000 00000000
You’re viewing 5 of 8 competitors. Get the full list »

Hemovent Patents

  • 26

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 6

    Pending

  • 000

    Expiring in next 12 mo

Hemovent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-112020003267-A5 Blood test device Pending 09-Jul-2019 000000000
EP-3997442-A1 Blood testing device Pending 09-Jul-2019 000000000
US-20220355003-A1 Blood testing device Pending 09-Jul-2019 000000000
DE-112019000979-A5 Holding device for holding an oxygenator and a blood pump Pending 26-Feb-2018 0000000000
EP-3758769-A1 Holding device for holding an oxygenator and a blood pump Pending 26-Feb-2018 A61M1/1652
To view Hemovent’s complete patent history, request access »

Hemovent Executive Team (2)

Name Title Board Seat Contact Info
Christof Lenz Co-Founder & Chief Executive Officer
Oliver Marseille Ph.D Co-Founder, Chief Technology Officer & Entrepreneur
To view Hemovent’s complete executive team members history, request access »

Hemovent Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemovent Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
First Capital Partner Venture Capital Minority 000 0000 000000 0
German Accelerator Accelerator/Incubator 000 0000 000000 0
Government of Germany Government 000 0000 000000 0
KfW Group Investment Bank Minority 000 0000 000000 0
MIG AG Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial